CRH (CRH) Upgraded to Buy: Here's Why
Werte in diesem Artikel
Investors might want to bet on CRH (CRH), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.As such, the Zacks rating upgrade for CRH is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for CRH imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>>.Earnings Estimate Revisions for CRHFor the fiscal year ending December 2024, this building material company is expected to earn $5.44 per share, which is a change of 17.8% from the year-ago reported number.Analysts have been steadily raising their estimates for CRH. Over the past three months, the Zacks Consensus Estimate for the company has increased 2.2%.Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of 'buy' and 'sell' ratings for its entire universe of more than 4000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a 'Strong Buy' rating and the next 15% get a 'Buy' rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.You can learn more about the Zacks Rank here >>>The upgrade of CRH to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CRH PLC (CRH): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf CRH
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CRH
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu CRH plc
Analysen zu CRH plc
Datum | Rating | Analyst | |
---|---|---|---|
06.10.2023 | CRH Buy | Jefferies & Company Inc. | |
27.09.2023 | CRH Buy | Jefferies & Company Inc. | |
26.09.2023 | CRH Buy | UBS AG | |
13.09.2023 | CRH Overweight | JP Morgan Chase & Co. | |
12.09.2023 | CRH Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
06.10.2023 | CRH Buy | Jefferies & Company Inc. | |
27.09.2023 | CRH Buy | Jefferies & Company Inc. | |
26.09.2023 | CRH Buy | UBS AG | |
13.09.2023 | CRH Overweight | JP Morgan Chase & Co. | |
12.09.2023 | CRH Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
13.07.2022 | CRH Equal-weight | Morgan Stanley | |
15.03.2022 | CRH Equal-weight | Morgan Stanley | |
04.03.2022 | CRH Equal Weight | Barclays Capital | |
19.01.2022 | CRH Equal Weight | Barclays Capital | |
17.12.2021 | CRH Hold | Kepler Cheuvreux |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CRH plc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen